| Intrinsic Valuation of: GLENMARK | |||||||||||
| Free Cash Flow Average and Growth over past 5Y | Key Statistics | ||||||||||
| Year | FCF | FCF (FCF/Revenue) | |||||||||
| 2020 | - | - | EPS (FY) | 37 | Market Cap | ₹495B | |||||
| 2021 | - | - (-) | P/E Ratio | 47 | Total Asset | ₹160B | |||||
| 2022 | ₹3B | - (-) | Net Income | ₹10B | Total Debt | ₹5B | |||||
| 2023 | ₹176M | -94.5% (-94.1%) | EBITDA | ₹21B | Total Liab | ₹72B | |||||
| 2024 | ₹-12B | -6701.7% (-6586.3%) | Opr Margin | 0.14 | Debt/Equity | 0.06 | |||||
| 2025 | ₹-16B | -35.5% (-19.9%) | PreTax Margin | 12.61 | BV/Share | 262 | |||||
| 5Y Average FCF | ₹-6B | -2277.2% (-2233.4%) | |||||||||
| Overall Market Assumptions: | |||||||||||
| Assumptions: | P/E for No-Growth Company: | 7.0 | |||||||||
| Perpetual Growth Rate (g): | 2.5% | Historical US Bond Yield: | 4.4% | ||||||||
| Discount Rate (WACC): | 7.4% | Current US Bond Yield: | 3.5% | ||||||||
| Forcasting Future Free Cash Flow for next 6Y | Modified Benjamin Graham's Intrinsic Value | ||||||||||
| Year | FCF Projection (4.0%) | ||||||||||
| 2026 | ₹-6B | MBG Intrinsic Value | ₹331 | ||||||||
| 2027 | ₹-7B | ||||||||||
| 2028 | ₹-7B | ||||||||||
| 2029 | ₹-7B | ||||||||||
| 2030 | ₹-7B | ||||||||||
| 2031 | ₹-8B | ||||||||||
| Terminal Value | ₹-158B | Net Worth/Share | ₹314 | ||||||||
| DCF Valuation | DCF Valuation "What If" Scenario Table | ||||||||||
| Enterprise Value | ₹-135B | Growth Rate | |||||||||
| (+) Cash & Cash Equivalents | ₹17B | ₹-438 | 1.5% | 2.0% | 2.5% | 3.0% | 3.5% | ||||
| (-) Total Debt | ₹5B | WACC | 7.3% | -380 | -411 | -448 | -493 | -550 | |||
| Equity Value | ₹-124B | 7.4% | -377 | -407 | -443 | -487 | -542 | ||||
| Shares Outstanding | 282,200,992 | 7.4% | -373 | -402 | -438 | -481 | -535 | ||||
| 7.9% | -340 | -365 | -393 | -428 | -470 | ||||||
| DCF Intrinsic Value | ₹-438 | 8.4% | -312 | -333 | -356 | -384 | -418 | ||||
| Analyzed by QuantJuice (2025) | |||||||||||